O ROURKE & COMPANY Inc Cuts Stake in iShares Biotechnology ETF (NASDAQ:IBB)

O ROURKE & COMPANY Inc decreased its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 2.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,625 shares of the financial services provider’s stock after selling 142 shares during the period. […]

Leave a Reply

Your email address will not be published.

Previous post First Boston Planning Department in 70 years gets to work at City Hall
Next post The Carlyle Group Inc. (NASDAQ:CG) Shares Acquired by O ROURKE & COMPANY Inc